Brimonidine Tartrate topical and Dexbrompheniramine and Pseudoephedrine Solution
Determining the interaction of Brimonidine Tartrate topical and Dexbrompheniramine and Pseudoephedrine Solution and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:After using brimonidine topical, some of the medication may be absorbed into the bloodstream and occasionally produce central nervous system side effects such as dizziness, drowsiness, and difficulty concentrating. Combining it with dexbrompheniramine or other medications that can also have these effects may increase the risk. You should avoid or limit the use of alcohol while being treated with these medications. Also avoid activities requiring mental alertness such as driving or operating hazardous machinery until you know how the medications affect you, and use caution when getting up from a sitting or lying position. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: Topically administered alpha-2 adrenergic receptor agonists such as apraclonidine and brimonidine are systemically absorbed, with the potential for producing rare but clinically significant systemic effects. Although the interaction has not been specifically studied, the possibility of an additive or potentiating effect with central nervous system (CNS) depressants such as alcohol, barbiturates, opiates, anxiolytics, sedatives, and anesthetics should be considered. Additive hypotensive effects and orthostasis may also occur with some CNS depressants and other agents that have these effects, particularly during initial dosing and/or parenteral administration.
MANAGEMENT: Patients receiving topical alpha-2 adrenergic receptor agonists in combination with agents that can cause CNS depression should be made aware of the potential for increased adverse effects such as drowsiness, dizziness, lightheadedness and confusion, and counseled to avoid activities requiring mental alertness until they know how these agents affect them. Patients should also avoid rising abruptly from a sitting or recumbent position and notify their physician if they experience orthostasis or tachycardia.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- "Product Information. Iopidine (apraclonidine)." Alcon Laboratories Inc, Fort Worth, TX.
- Pekdemir M, Yanturali S, Karakus G "More than just an ocular solution." Emerg Med J 22 (2005): 753-4
- "Product Information. Alphagan (brimonidine ophthalmic)." Allergan Inc, Irvine, CA.
- "Product Information. Mirvaso (brimonidine topical)." Galderma Laboratories Inc, Cranbury, NJ.
Generic Name: brimonidine topical
Brand name: Mirvaso, Mirvaso Pump
Synonyms: Brimonidine (Topical), Brimonidine topical
Generic Name: dexbrompheniramine / pseudoephedrine
Brand name: Conex, Drixoral Cold and Allergy, Drexophed SR, Desihist SA, Duomine, Dexophed, Disobrom, Disophrol, Drixoral, 12 Hour Cold, Dexaphen SA, Dixaphedrine, Drixomed, Pharmadrine, Ala Hist PE, Ala-Hist PE, Drixoral Sinus
Synonyms: Dexbrompheniramine and pseudoephedrine, Brompheniramine and Pseudoephedrine Drops
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brimonidine Tartrate topical-Dexbrompheniramine and Pseudoephedrine Sustained-Release Tablets
- Brimonidine Tartrate topical-Dexbrompheniramine and Pseudoephedrine Tablets
- Brimonidine Tartrate topical-Dexbrompheniramine Tablets
- Brimonidine Tartrate topical-Dexbrompheniramine, dextromethorphan, and phenylephrine
- Brimonidine Tartrate topical-Dexbrompheniramine, Dextromethorphan, and Phenylephrine Liquid
- Brimonidine Tartrate topical-Dexbrompheniramine, dextromethorphan, and pseudoephedrine
- Dexbrompheniramine and Pseudoephedrine Solution-Brimonidine topical
- Dexbrompheniramine and Pseudoephedrine Solution-Brimonidine Topical application
- Dexbrompheniramine and Pseudoephedrine Solution-Brintellix
- Dexbrompheniramine and Pseudoephedrine Solution-Brinzolamide
- Dexbrompheniramine and Pseudoephedrine Solution-Brinzolamide and Brimonidine
- Dexbrompheniramine and Pseudoephedrine Solution-Brinzolamide ophthalmic